Valuation : OrganiGram

Market Cap 207M 149M 129M 122M 110M 14.25B 208M 1.45B 556M 7.25B 560M 548M 22.91B P/E 2026 *
1.82x
P/E 2027 * 18.4x
Enterprise Value 207M 149M 129M 122M 110M 14.25B 208M 1.45B 556M 7.25B 560M 548M 22.91B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.45x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 150M
+0.52%-1.37%+15.20%+171.70% 350M
+0.34%-7.23%-35.59%-41.70% 150M
+1.28%-0.50%+15.12%+102.04% 140M
+6.59%+4.30%-29.71%-62.11% 92.49M
-1.41%-0.49%-40.46%-48.25% 62.82M
Average +0.57%-1.30%-15.09%+24.34% 158.91M
Weighted average by Cap. +0.37%-1.71%-4.02%+74.62%

Financials

2026 *2027 *
Net sales 350M 252M 217M 206M 186M 24.09B 352M 2.44B 939M 12.25B 947M 926M 38.72B 458M 330M 284M 269M 244M 31.55B 460M 3.2B 1.23B 16.05B 1.24B 1.21B 50.71B
Net income 128M 92.49M 79.69M 75.45M 68.39M 8.84B 129M 896M 345M 4.5B 347M 340M 14.2B 8.1M 5.84M 5.03M 4.76M 4.32M 558M 8.14M 56.57M 21.76M 284M 21.93M 21.45M 897M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!